Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 55,592 shares at $93.18 ($5.2M) on 2019-03-19, disclosed to the SEC on 2019-03-21.
Open-market sale of $5.2M RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.18 | 19,947 | $1.9M | 35.8% |
| 2 | $93.18 | 19,947 | $1.9M | 35.8% |
| 3 | $94.16 | 7,249 | $683K | 13.1% |
| 4 | $94.16 | 7,249 | $683K | 13.1% |
| 5 | $95.01 | 1,100 | $105K | 2.0% |
| 6 | $95.69 | 100 |
| $10K |
| 0.2% |
| Total | $93.47 avg | 55,592 | $5.2M | 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |